Alnylam Pharmaceuticals
ALNY
#568
Rank
$43.87 B
Marketcap
$330.82
Share price
-0.13%
Change (1 day)
35.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company